Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
With his skills on the abacus,
Man City would be a good career move.
Cut him some slack. He was likely up all night counting with his fingers.
Cut him some slack, it's difficult using your calculator single handed when you're busy trying to reduce your prostate cancer risk with the other hand.
Apologies PL, couldn't resist.
Zżzzzzźźzzzzzzzzzzzzz
If AS and the CFO resigned (watch this space) how do you think the market would react?
You tell me, what has taken place that has been better than expected, given the incredibly high bar from when we started?
Time line has over run by years, causing more cash raises and dilution than ever contemplated. Results are partial, There is a lot of key info we don't know, but given where the raise was pitched I make the assumption that its "promising" as opposed to pardigm shifting (at this stage).
Just my opinion, but you may be one of those that simply doesn't care about this stock as an investment.
Timing is everything. But again, you and I might be talking about different things.
Cut him some slack, it's difficult using your calculator when you're busy trying to reduce your prostate cancer risk with the same hand.
If BODMAS don't work the board must go!
Both calculations in the RNS are wrong with the same type of error. So the same mistake was made twice which means it isn't a simple calculator error. Probably a formula error on a spreadsheet but even simple calculations should be double and triple checked when informing the market. Maybe he did it deliberately knowing he's getting the elbow next week!!!
Maybe he used to work at the Post Office at BOD level....they struggle telling the truth
Are all the Abacus beads in place?
“ nothing to date has gone better than expected”
Are we looking at the same company?
Blame the shops for not checking slapdash absolute disgrace
It's only 2,058,000 adrift!!
That is shocking......you only have to read it once to to straight away see the mathematical error
5,277,257 + 6,500,000 - 2,058,000 = 11,777,257
¯\_(ツ)_/¯
Vote him out, No wonder we are in this mess.
Interesting start for sure. We have some buying pressure
Sorry...BST 6.54-15 seconds
IMO
Not not quite a binary play Sheps, as there is the DX division and that market is huge but in the short term that seems a ways off.
So its TX or bust (literally maybe?)
If W2D does go better than expected then I would expect a re rate to around 130-150p as it should com into the spotlight. From there if should trigger all sorts of interest
The potential down side that nothing to date has gone better than expected, and has co-incided with taking longer to, if not underwhelm, then weave on. This then makes this death spiral scenario more of a possibility, but I would expect at that stage it gets delisted and then bought out privately, bypassing the LTH's completely.
End game time now, as I said before. 18 months maybe , with some very key data releases along the way. No margin (imo) for any stumbles.
My "feeling" is given the ultimate lack lustre response of the market over the trial's time thus far, is that it isn't quite the magic bullet I perhaps thought. New platform with loads of potential, sure, but if it just trundles on then its years away still, with millions more to be spent before commercialisation, and as I say at the stage it will not be around as a PLC. (DYOR etc)
To be fair having been here over 4 years and having invested a fair amount of money (clearly not wisely so far) I think I know the difference between a vaccine and a targeting chemotherapy treatment which the texter in question was referring to....LBC catch up Ian Payne 7.54-15 seconds.
I sat looking at that for 10 minutes trying to work out if I was the idiot but seems not, this is the guy that is paid a lot of money to do the maths and we wonder why we are in the $hitter SP wise. Am I missing something with the numbers still convinced I am been daft as using a calulator is not that hard?
YES ,but on the back of this i cannot see AVCT ever getting to anywhere near £5 ,bought out early at a pittance
On a serious note forget the ramping and the deramping..
Do you think this share through whatever outcome will reach £1.20 again?